Global TYK2 Allosteric Inhibitor Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
The global TYK2 Allosteric Inhibitor market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “TYK2 Allosteric Inhibitor Industry Forecast” looks at past sales and reviews total world TYK2 Allosteric Inhibitor sales in 2023, providing a comprehensive analysis by region and market sector of projected TYK2 Allosteric Inhibitor sales for 2024 through 2030. With TYK2 Allosteric Inhibitor sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world TYK2 Allosteric Inhibitor industry.
This Insight Report provides a comprehensive analysis of the global TYK2 Allosteric Inhibitor landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on TYK2 Allosteric Inhibitor portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global TYK2 Allosteric Inhibitor market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for TYK2 Allosteric Inhibitor and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global TYK2 Allosteric Inhibitor.
United States market for TYK2 Allosteric Inhibitor is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for TYK2 Allosteric Inhibitor is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for TYK2 Allosteric Inhibitor is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key TYK2 Allosteric Inhibitor players cover Bristol-Myers Squibb, InnoCare Pharma, Takeda (Nimbus Therapeutics), Alumis Inc. and Ventyx Biosciences and etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of TYK2 Allosteric Inhibitor market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
What is the 10-year outlook for the global TYK2 Allosteric Inhibitor market?
What factors are driving TYK2 Allosteric Inhibitor market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do TYK2 Allosteric Inhibitor market opportunities vary by end market size?
How does TYK2 Allosteric Inhibitor break out type, application?
The global TYK2 Allosteric Inhibitor market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “TYK2 Allosteric Inhibitor Industry Forecast” looks at past sales and reviews total world TYK2 Allosteric Inhibitor sales in 2023, providing a comprehensive analysis by region and market sector of projected TYK2 Allosteric Inhibitor sales for 2024 through 2030. With TYK2 Allosteric Inhibitor sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world TYK2 Allosteric Inhibitor industry.
This Insight Report provides a comprehensive analysis of the global TYK2 Allosteric Inhibitor landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on TYK2 Allosteric Inhibitor portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global TYK2 Allosteric Inhibitor market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for TYK2 Allosteric Inhibitor and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global TYK2 Allosteric Inhibitor.
United States market for TYK2 Allosteric Inhibitor is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for TYK2 Allosteric Inhibitor is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for TYK2 Allosteric Inhibitor is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key TYK2 Allosteric Inhibitor players cover Bristol-Myers Squibb, InnoCare Pharma, Takeda (Nimbus Therapeutics), Alumis Inc. and Ventyx Biosciences and etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of TYK2 Allosteric Inhibitor market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
- Oral Preparations
- Topical Drugs
- Psoriasis
- Atopic Dermatitis
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bristol-Myers Squibb
- InnoCare Pharma
- Takeda (Nimbus Therapeutics)
- Alumis Inc.
- Ventyx Biosciences
- BeiGene
What is the 10-year outlook for the global TYK2 Allosteric Inhibitor market?
What factors are driving TYK2 Allosteric Inhibitor market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do TYK2 Allosteric Inhibitor market opportunities vary by end market size?
How does TYK2 Allosteric Inhibitor break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global TYK2 Allosteric Inhibitor Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for TYK2 Allosteric Inhibitor by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for TYK2 Allosteric Inhibitor by Country/Region, 2019, 2023 & 2030
2.2 TYK2 Allosteric Inhibitor Segment by Type
2.2.1 Oral Preparations
2.2.2 Topical Drugs
2.3 TYK2 Allosteric Inhibitor Sales by Type
2.3.1 Global TYK2 Allosteric Inhibitor Sales Market Share by Type (2019-2024)
2.3.2 Global TYK2 Allosteric Inhibitor Revenue and Market Share by Type (2019-2024)
2.3.3 Global TYK2 Allosteric Inhibitor Sale Price by Type (2019-2024)
2.4 TYK2 Allosteric Inhibitor Segment by Application
2.4.1 Psoriasis
2.4.2 Atopic Dermatitis
2.4.3 Other
2.5 TYK2 Allosteric Inhibitor Sales by Application
2.5.1 Global TYK2 Allosteric Inhibitor Sale Market Share by Application (2019-2024)
2.5.2 Global TYK2 Allosteric Inhibitor Revenue and Market Share by Application (2019-2024)
2.5.3 Global TYK2 Allosteric Inhibitor Sale Price by Application (2019-2024)
3 GLOBAL TYK2 ALLOSTERIC INHIBITOR BY COMPANY
3.1 Global TYK2 Allosteric Inhibitor Breakdown Data by Company
3.1.1 Global TYK2 Allosteric Inhibitor Annual Sales by Company (2019-2024)
3.1.2 Global TYK2 Allosteric Inhibitor Sales Market Share by Company (2019-2024)
3.2 Global TYK2 Allosteric Inhibitor Annual Revenue by Company (2019-2024)
3.2.1 Global TYK2 Allosteric Inhibitor Revenue by Company (2019-2024)
3.2.2 Global TYK2 Allosteric Inhibitor Revenue Market Share by Company (2019-2024)
3.3 Global TYK2 Allosteric Inhibitor Sale Price by Company
3.4 Key Manufacturers TYK2 Allosteric Inhibitor Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers TYK2 Allosteric Inhibitor Product Location Distribution
3.4.2 Players TYK2 Allosteric Inhibitor Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR TYK2 ALLOSTERIC INHIBITOR BY GEOGRAPHIC REGION
4.1 World Historic TYK2 Allosteric Inhibitor Market Size by Geographic Region (2019-2024)
4.1.1 Global TYK2 Allosteric Inhibitor Annual Sales by Geographic Region (2019-2024)
4.1.2 Global TYK2 Allosteric Inhibitor Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic TYK2 Allosteric Inhibitor Market Size by Country/Region (2019-2024)
4.2.1 Global TYK2 Allosteric Inhibitor Annual Sales by Country/Region (2019-2024)
4.2.2 Global TYK2 Allosteric Inhibitor Annual Revenue by Country/Region (2019-2024)
4.3 Americas TYK2 Allosteric Inhibitor Sales Growth
4.4 APAC TYK2 Allosteric Inhibitor Sales Growth
4.5 Europe TYK2 Allosteric Inhibitor Sales Growth
4.6 Middle East & Africa TYK2 Allosteric Inhibitor Sales Growth
5 AMERICAS
5.1 Americas TYK2 Allosteric Inhibitor Sales by Country
5.1.1 Americas TYK2 Allosteric Inhibitor Sales by Country (2019-2024)
5.1.2 Americas TYK2 Allosteric Inhibitor Revenue by Country (2019-2024)
5.2 Americas TYK2 Allosteric Inhibitor Sales by Type
5.3 Americas TYK2 Allosteric Inhibitor Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC TYK2 Allosteric Inhibitor Sales by Region
6.1.1 APAC TYK2 Allosteric Inhibitor Sales by Region (2019-2024)
6.1.2 APAC TYK2 Allosteric Inhibitor Revenue by Region (2019-2024)
6.2 APAC TYK2 Allosteric Inhibitor Sales by Type
6.3 APAC TYK2 Allosteric Inhibitor Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe TYK2 Allosteric Inhibitor by Country
7.1.1 Europe TYK2 Allosteric Inhibitor Sales by Country (2019-2024)
7.1.2 Europe TYK2 Allosteric Inhibitor Revenue by Country (2019-2024)
7.2 Europe TYK2 Allosteric Inhibitor Sales by Type
7.3 Europe TYK2 Allosteric Inhibitor Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa TYK2 Allosteric Inhibitor by Country
8.1.1 Middle East & Africa TYK2 Allosteric Inhibitor Sales by Country (2019-2024)
8.1.2 Middle East & Africa TYK2 Allosteric Inhibitor Revenue by Country (2019-2024)
8.2 Middle East & Africa TYK2 Allosteric Inhibitor Sales by Type
8.3 Middle East & Africa TYK2 Allosteric Inhibitor Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of TYK2 Allosteric Inhibitor
10.3 Manufacturing Process Analysis of TYK2 Allosteric Inhibitor
10.4 Industry Chain Structure of TYK2 Allosteric Inhibitor
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 TYK2 Allosteric Inhibitor Distributors
11.3 TYK2 Allosteric Inhibitor Customer
12 WORLD FORECAST REVIEW FOR TYK2 ALLOSTERIC INHIBITOR BY GEOGRAPHIC REGION
12.1 Global TYK2 Allosteric Inhibitor Market Size Forecast by Region
12.1.1 Global TYK2 Allosteric Inhibitor Forecast by Region (2025-2030)
12.1.2 Global TYK2 Allosteric Inhibitor Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global TYK2 Allosteric Inhibitor Forecast by Type
12.7 Global TYK2 Allosteric Inhibitor Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Bristol-Myers Squibb
13.1.1 Bristol-Myers Squibb Company Information
13.1.2 Bristol-Myers Squibb TYK2 Allosteric Inhibitor Product Portfolios and Specifications
13.1.3 Bristol-Myers Squibb TYK2 Allosteric Inhibitor Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Bristol-Myers Squibb Main Business Overview
13.1.5 Bristol-Myers Squibb Latest Developments
13.2 InnoCare Pharma
13.2.1 InnoCare Pharma Company Information
13.2.2 InnoCare Pharma TYK2 Allosteric Inhibitor Product Portfolios and Specifications
13.2.3 InnoCare Pharma TYK2 Allosteric Inhibitor Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 InnoCare Pharma Main Business Overview
13.2.5 InnoCare Pharma Latest Developments
13.3 Takeda (Nimbus Therapeutics)
13.3.1 Takeda (Nimbus Therapeutics) Company Information
13.3.2 Takeda (Nimbus Therapeutics) TYK2 Allosteric Inhibitor Product Portfolios and Specifications
13.3.3 Takeda (Nimbus Therapeutics) TYK2 Allosteric Inhibitor Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Takeda (Nimbus Therapeutics) Main Business Overview
13.3.5 Takeda (Nimbus Therapeutics) Latest Developments
13.4 Alumis Inc.
13.4.1 Alumis Inc. Company Information
13.4.2 Alumis Inc. TYK2 Allosteric Inhibitor Product Portfolios and Specifications
13.4.3 Alumis Inc. TYK2 Allosteric Inhibitor Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Alumis Inc. Main Business Overview
13.4.5 Alumis Inc. Latest Developments
13.5 Ventyx Biosciences
13.5.1 Ventyx Biosciences Company Information
13.5.2 Ventyx Biosciences TYK2 Allosteric Inhibitor Product Portfolios and Specifications
13.5.3 Ventyx Biosciences TYK2 Allosteric Inhibitor Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Ventyx Biosciences Main Business Overview
13.5.5 Ventyx Biosciences Latest Developments
13.6 BeiGene
13.6.1 BeiGene Company Information
13.6.2 BeiGene TYK2 Allosteric Inhibitor Product Portfolios and Specifications
13.6.3 BeiGene TYK2 Allosteric Inhibitor Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 BeiGene Main Business Overview
13.6.5 BeiGene Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global TYK2 Allosteric Inhibitor Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for TYK2 Allosteric Inhibitor by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for TYK2 Allosteric Inhibitor by Country/Region, 2019, 2023 & 2030
2.2 TYK2 Allosteric Inhibitor Segment by Type
2.2.1 Oral Preparations
2.2.2 Topical Drugs
2.3 TYK2 Allosteric Inhibitor Sales by Type
2.3.1 Global TYK2 Allosteric Inhibitor Sales Market Share by Type (2019-2024)
2.3.2 Global TYK2 Allosteric Inhibitor Revenue and Market Share by Type (2019-2024)
2.3.3 Global TYK2 Allosteric Inhibitor Sale Price by Type (2019-2024)
2.4 TYK2 Allosteric Inhibitor Segment by Application
2.4.1 Psoriasis
2.4.2 Atopic Dermatitis
2.4.3 Other
2.5 TYK2 Allosteric Inhibitor Sales by Application
2.5.1 Global TYK2 Allosteric Inhibitor Sale Market Share by Application (2019-2024)
2.5.2 Global TYK2 Allosteric Inhibitor Revenue and Market Share by Application (2019-2024)
2.5.3 Global TYK2 Allosteric Inhibitor Sale Price by Application (2019-2024)
3 GLOBAL TYK2 ALLOSTERIC INHIBITOR BY COMPANY
3.1 Global TYK2 Allosteric Inhibitor Breakdown Data by Company
3.1.1 Global TYK2 Allosteric Inhibitor Annual Sales by Company (2019-2024)
3.1.2 Global TYK2 Allosteric Inhibitor Sales Market Share by Company (2019-2024)
3.2 Global TYK2 Allosteric Inhibitor Annual Revenue by Company (2019-2024)
3.2.1 Global TYK2 Allosteric Inhibitor Revenue by Company (2019-2024)
3.2.2 Global TYK2 Allosteric Inhibitor Revenue Market Share by Company (2019-2024)
3.3 Global TYK2 Allosteric Inhibitor Sale Price by Company
3.4 Key Manufacturers TYK2 Allosteric Inhibitor Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers TYK2 Allosteric Inhibitor Product Location Distribution
3.4.2 Players TYK2 Allosteric Inhibitor Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR TYK2 ALLOSTERIC INHIBITOR BY GEOGRAPHIC REGION
4.1 World Historic TYK2 Allosteric Inhibitor Market Size by Geographic Region (2019-2024)
4.1.1 Global TYK2 Allosteric Inhibitor Annual Sales by Geographic Region (2019-2024)
4.1.2 Global TYK2 Allosteric Inhibitor Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic TYK2 Allosteric Inhibitor Market Size by Country/Region (2019-2024)
4.2.1 Global TYK2 Allosteric Inhibitor Annual Sales by Country/Region (2019-2024)
4.2.2 Global TYK2 Allosteric Inhibitor Annual Revenue by Country/Region (2019-2024)
4.3 Americas TYK2 Allosteric Inhibitor Sales Growth
4.4 APAC TYK2 Allosteric Inhibitor Sales Growth
4.5 Europe TYK2 Allosteric Inhibitor Sales Growth
4.6 Middle East & Africa TYK2 Allosteric Inhibitor Sales Growth
5 AMERICAS
5.1 Americas TYK2 Allosteric Inhibitor Sales by Country
5.1.1 Americas TYK2 Allosteric Inhibitor Sales by Country (2019-2024)
5.1.2 Americas TYK2 Allosteric Inhibitor Revenue by Country (2019-2024)
5.2 Americas TYK2 Allosteric Inhibitor Sales by Type
5.3 Americas TYK2 Allosteric Inhibitor Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC TYK2 Allosteric Inhibitor Sales by Region
6.1.1 APAC TYK2 Allosteric Inhibitor Sales by Region (2019-2024)
6.1.2 APAC TYK2 Allosteric Inhibitor Revenue by Region (2019-2024)
6.2 APAC TYK2 Allosteric Inhibitor Sales by Type
6.3 APAC TYK2 Allosteric Inhibitor Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe TYK2 Allosteric Inhibitor by Country
7.1.1 Europe TYK2 Allosteric Inhibitor Sales by Country (2019-2024)
7.1.2 Europe TYK2 Allosteric Inhibitor Revenue by Country (2019-2024)
7.2 Europe TYK2 Allosteric Inhibitor Sales by Type
7.3 Europe TYK2 Allosteric Inhibitor Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa TYK2 Allosteric Inhibitor by Country
8.1.1 Middle East & Africa TYK2 Allosteric Inhibitor Sales by Country (2019-2024)
8.1.2 Middle East & Africa TYK2 Allosteric Inhibitor Revenue by Country (2019-2024)
8.2 Middle East & Africa TYK2 Allosteric Inhibitor Sales by Type
8.3 Middle East & Africa TYK2 Allosteric Inhibitor Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of TYK2 Allosteric Inhibitor
10.3 Manufacturing Process Analysis of TYK2 Allosteric Inhibitor
10.4 Industry Chain Structure of TYK2 Allosteric Inhibitor
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 TYK2 Allosteric Inhibitor Distributors
11.3 TYK2 Allosteric Inhibitor Customer
12 WORLD FORECAST REVIEW FOR TYK2 ALLOSTERIC INHIBITOR BY GEOGRAPHIC REGION
12.1 Global TYK2 Allosteric Inhibitor Market Size Forecast by Region
12.1.1 Global TYK2 Allosteric Inhibitor Forecast by Region (2025-2030)
12.1.2 Global TYK2 Allosteric Inhibitor Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global TYK2 Allosteric Inhibitor Forecast by Type
12.7 Global TYK2 Allosteric Inhibitor Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Bristol-Myers Squibb
13.1.1 Bristol-Myers Squibb Company Information
13.1.2 Bristol-Myers Squibb TYK2 Allosteric Inhibitor Product Portfolios and Specifications
13.1.3 Bristol-Myers Squibb TYK2 Allosteric Inhibitor Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Bristol-Myers Squibb Main Business Overview
13.1.5 Bristol-Myers Squibb Latest Developments
13.2 InnoCare Pharma
13.2.1 InnoCare Pharma Company Information
13.2.2 InnoCare Pharma TYK2 Allosteric Inhibitor Product Portfolios and Specifications
13.2.3 InnoCare Pharma TYK2 Allosteric Inhibitor Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 InnoCare Pharma Main Business Overview
13.2.5 InnoCare Pharma Latest Developments
13.3 Takeda (Nimbus Therapeutics)
13.3.1 Takeda (Nimbus Therapeutics) Company Information
13.3.2 Takeda (Nimbus Therapeutics) TYK2 Allosteric Inhibitor Product Portfolios and Specifications
13.3.3 Takeda (Nimbus Therapeutics) TYK2 Allosteric Inhibitor Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Takeda (Nimbus Therapeutics) Main Business Overview
13.3.5 Takeda (Nimbus Therapeutics) Latest Developments
13.4 Alumis Inc.
13.4.1 Alumis Inc. Company Information
13.4.2 Alumis Inc. TYK2 Allosteric Inhibitor Product Portfolios and Specifications
13.4.3 Alumis Inc. TYK2 Allosteric Inhibitor Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Alumis Inc. Main Business Overview
13.4.5 Alumis Inc. Latest Developments
13.5 Ventyx Biosciences
13.5.1 Ventyx Biosciences Company Information
13.5.2 Ventyx Biosciences TYK2 Allosteric Inhibitor Product Portfolios and Specifications
13.5.3 Ventyx Biosciences TYK2 Allosteric Inhibitor Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Ventyx Biosciences Main Business Overview
13.5.5 Ventyx Biosciences Latest Developments
13.6 BeiGene
13.6.1 BeiGene Company Information
13.6.2 BeiGene TYK2 Allosteric Inhibitor Product Portfolios and Specifications
13.6.3 BeiGene TYK2 Allosteric Inhibitor Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 BeiGene Main Business Overview
13.6.5 BeiGene Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. TYK2 Allosteric Inhibitor Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. TYK2 Allosteric Inhibitor Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Oral Preparations
Table 4. Major Players of Topical Drugs
Table 5. Global TYK2 Allosteric Inhibitor Sales by Type (2019-2024) & (K Units)
Table 6. Global TYK2 Allosteric Inhibitor Sales Market Share by Type (2019-2024)
Table 7. Global TYK2 Allosteric Inhibitor Revenue by Type (2019-2024) & ($ million)
Table 8. Global TYK2 Allosteric Inhibitor Revenue Market Share by Type (2019-2024)
Table 9. Global TYK2 Allosteric Inhibitor Sale Price by Type (2019-2024) & (US$/Unit)
Table 10. Global TYK2 Allosteric Inhibitor Sales by Application (2019-2024) & (K Units)
Table 11. Global TYK2 Allosteric Inhibitor Sales Market Share by Application (2019-2024)
Table 12. Global TYK2 Allosteric Inhibitor Revenue by Application (2019-2024)
Table 13. Global TYK2 Allosteric Inhibitor Revenue Market Share by Application (2019-2024)
Table 14. Global TYK2 Allosteric Inhibitor Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global TYK2 Allosteric Inhibitor Sales by Company (2019-2024) & (K Units)
Table 16. Global TYK2 Allosteric Inhibitor Sales Market Share by Company (2019-2024)
Table 17. Global TYK2 Allosteric Inhibitor Revenue by Company (2019-2024) ($ Millions)
Table 18. Global TYK2 Allosteric Inhibitor Revenue Market Share by Company (2019-2024)
Table 19. Global TYK2 Allosteric Inhibitor Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers TYK2 Allosteric Inhibitor Producing Area Distribution and Sales Area
Table 21. Players TYK2 Allosteric Inhibitor Products Offered
Table 22. TYK2 Allosteric Inhibitor Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global TYK2 Allosteric Inhibitor Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global TYK2 Allosteric Inhibitor Sales Market Share Geographic Region (2019-2024)
Table 27. Global TYK2 Allosteric Inhibitor Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global TYK2 Allosteric Inhibitor Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global TYK2 Allosteric Inhibitor Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global TYK2 Allosteric Inhibitor Sales Market Share by Country/Region (2019-2024)
Table 31. Global TYK2 Allosteric Inhibitor Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global TYK2 Allosteric Inhibitor Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas TYK2 Allosteric Inhibitor Sales by Country (2019-2024) & (K Units)
Table 34. Americas TYK2 Allosteric Inhibitor Sales Market Share by Country (2019-2024)
Table 35. Americas TYK2 Allosteric Inhibitor Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas TYK2 Allosteric Inhibitor Revenue Market Share by Country (2019-2024)
Table 37. Americas TYK2 Allosteric Inhibitor Sales by Type (2019-2024) & (K Units)
Table 38. Americas TYK2 Allosteric Inhibitor Sales by Application (2019-2024) & (K Units)
Table 39. APAC TYK2 Allosteric Inhibitor Sales by Region (2019-2024) & (K Units)
Table 40. APAC TYK2 Allosteric Inhibitor Sales Market Share by Region (2019-2024)
Table 41. APAC TYK2 Allosteric Inhibitor Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC TYK2 Allosteric Inhibitor Revenue Market Share by Region (2019-2024)
Table 43. APAC TYK2 Allosteric Inhibitor Sales by Type (2019-2024) & (K Units)
Table 44. APAC TYK2 Allosteric Inhibitor Sales by Application (2019-2024) & (K Units)
Table 45. Europe TYK2 Allosteric Inhibitor Sales by Country (2019-2024) & (K Units)
Table 46. Europe TYK2 Allosteric Inhibitor Sales Market Share by Country (2019-2024)
Table 47. Europe TYK2 Allosteric Inhibitor Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe TYK2 Allosteric Inhibitor Revenue Market Share by Country (2019-2024)
Table 49. Europe TYK2 Allosteric Inhibitor Sales by Type (2019-2024) & (K Units)
Table 50. Europe TYK2 Allosteric Inhibitor Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa TYK2 Allosteric Inhibitor Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa TYK2 Allosteric Inhibitor Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa TYK2 Allosteric Inhibitor Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa TYK2 Allosteric Inhibitor Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa TYK2 Allosteric Inhibitor Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa TYK2 Allosteric Inhibitor Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of TYK2 Allosteric Inhibitor
Table 58. Key Market Challenges & Risks of TYK2 Allosteric Inhibitor
Table 59. Key Industry Trends of TYK2 Allosteric Inhibitor
Table 60. TYK2 Allosteric Inhibitor Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. TYK2 Allosteric Inhibitor Distributors List
Table 63. TYK2 Allosteric Inhibitor Customer List
Table 64. Global TYK2 Allosteric Inhibitor Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global TYK2 Allosteric Inhibitor Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas TYK2 Allosteric Inhibitor Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas TYK2 Allosteric Inhibitor Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC TYK2 Allosteric Inhibitor Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC TYK2 Allosteric Inhibitor Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe TYK2 Allosteric Inhibitor Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe TYK2 Allosteric Inhibitor Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa TYK2 Allosteric Inhibitor Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa TYK2 Allosteric Inhibitor Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global TYK2 Allosteric Inhibitor Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global TYK2 Allosteric Inhibitor Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global TYK2 Allosteric Inhibitor Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global TYK2 Allosteric Inhibitor Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Bristol-Myers Squibb Basic Information, TYK2 Allosteric Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 79. Bristol-Myers Squibb TYK2 Allosteric Inhibitor Product Portfolios and Specifications
Table 80. Bristol-Myers Squibb TYK2 Allosteric Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. Bristol-Myers Squibb Main Business
Table 82. Bristol-Myers Squibb Latest Developments
Table 83. InnoCare Pharma Basic Information, TYK2 Allosteric Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 84. InnoCare Pharma TYK2 Allosteric Inhibitor Product Portfolios and Specifications
Table 85. InnoCare Pharma TYK2 Allosteric Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. InnoCare Pharma Main Business
Table 87. InnoCare Pharma Latest Developments
Table 88. Takeda (Nimbus Therapeutics) Basic Information, TYK2 Allosteric Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 89. Takeda (Nimbus Therapeutics) TYK2 Allosteric Inhibitor Product Portfolios and Specifications
Table 90. Takeda (Nimbus Therapeutics) TYK2 Allosteric Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. Takeda (Nimbus Therapeutics) Main Business
Table 92. Takeda (Nimbus Therapeutics) Latest Developments
Table 93. Alumis Inc. Basic Information, TYK2 Allosteric Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 94. Alumis Inc. TYK2 Allosteric Inhibitor Product Portfolios and Specifications
Table 95. Alumis Inc. TYK2 Allosteric Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. Alumis Inc. Main Business
Table 97. Alumis Inc. Latest Developments
Table 98. Ventyx Biosciences Basic Information, TYK2 Allosteric Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 99. Ventyx Biosciences TYK2 Allosteric Inhibitor Product Portfolios and Specifications
Table 100. Ventyx Biosciences TYK2 Allosteric Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. Ventyx Biosciences Main Business
Table 102. Ventyx Biosciences Latest Developments
Table 103. BeiGene Basic Information, TYK2 Allosteric Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 104. BeiGene TYK2 Allosteric Inhibitor Product Portfolios and Specifications
Table 105. BeiGene TYK2 Allosteric Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. BeiGene Main Business
Table 107. BeiGene Latest Developments
Table 1. TYK2 Allosteric Inhibitor Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. TYK2 Allosteric Inhibitor Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Oral Preparations
Table 4. Major Players of Topical Drugs
Table 5. Global TYK2 Allosteric Inhibitor Sales by Type (2019-2024) & (K Units)
Table 6. Global TYK2 Allosteric Inhibitor Sales Market Share by Type (2019-2024)
Table 7. Global TYK2 Allosteric Inhibitor Revenue by Type (2019-2024) & ($ million)
Table 8. Global TYK2 Allosteric Inhibitor Revenue Market Share by Type (2019-2024)
Table 9. Global TYK2 Allosteric Inhibitor Sale Price by Type (2019-2024) & (US$/Unit)
Table 10. Global TYK2 Allosteric Inhibitor Sales by Application (2019-2024) & (K Units)
Table 11. Global TYK2 Allosteric Inhibitor Sales Market Share by Application (2019-2024)
Table 12. Global TYK2 Allosteric Inhibitor Revenue by Application (2019-2024)
Table 13. Global TYK2 Allosteric Inhibitor Revenue Market Share by Application (2019-2024)
Table 14. Global TYK2 Allosteric Inhibitor Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global TYK2 Allosteric Inhibitor Sales by Company (2019-2024) & (K Units)
Table 16. Global TYK2 Allosteric Inhibitor Sales Market Share by Company (2019-2024)
Table 17. Global TYK2 Allosteric Inhibitor Revenue by Company (2019-2024) ($ Millions)
Table 18. Global TYK2 Allosteric Inhibitor Revenue Market Share by Company (2019-2024)
Table 19. Global TYK2 Allosteric Inhibitor Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers TYK2 Allosteric Inhibitor Producing Area Distribution and Sales Area
Table 21. Players TYK2 Allosteric Inhibitor Products Offered
Table 22. TYK2 Allosteric Inhibitor Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global TYK2 Allosteric Inhibitor Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global TYK2 Allosteric Inhibitor Sales Market Share Geographic Region (2019-2024)
Table 27. Global TYK2 Allosteric Inhibitor Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global TYK2 Allosteric Inhibitor Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global TYK2 Allosteric Inhibitor Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global TYK2 Allosteric Inhibitor Sales Market Share by Country/Region (2019-2024)
Table 31. Global TYK2 Allosteric Inhibitor Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global TYK2 Allosteric Inhibitor Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas TYK2 Allosteric Inhibitor Sales by Country (2019-2024) & (K Units)
Table 34. Americas TYK2 Allosteric Inhibitor Sales Market Share by Country (2019-2024)
Table 35. Americas TYK2 Allosteric Inhibitor Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas TYK2 Allosteric Inhibitor Revenue Market Share by Country (2019-2024)
Table 37. Americas TYK2 Allosteric Inhibitor Sales by Type (2019-2024) & (K Units)
Table 38. Americas TYK2 Allosteric Inhibitor Sales by Application (2019-2024) & (K Units)
Table 39. APAC TYK2 Allosteric Inhibitor Sales by Region (2019-2024) & (K Units)
Table 40. APAC TYK2 Allosteric Inhibitor Sales Market Share by Region (2019-2024)
Table 41. APAC TYK2 Allosteric Inhibitor Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC TYK2 Allosteric Inhibitor Revenue Market Share by Region (2019-2024)
Table 43. APAC TYK2 Allosteric Inhibitor Sales by Type (2019-2024) & (K Units)
Table 44. APAC TYK2 Allosteric Inhibitor Sales by Application (2019-2024) & (K Units)
Table 45. Europe TYK2 Allosteric Inhibitor Sales by Country (2019-2024) & (K Units)
Table 46. Europe TYK2 Allosteric Inhibitor Sales Market Share by Country (2019-2024)
Table 47. Europe TYK2 Allosteric Inhibitor Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe TYK2 Allosteric Inhibitor Revenue Market Share by Country (2019-2024)
Table 49. Europe TYK2 Allosteric Inhibitor Sales by Type (2019-2024) & (K Units)
Table 50. Europe TYK2 Allosteric Inhibitor Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa TYK2 Allosteric Inhibitor Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa TYK2 Allosteric Inhibitor Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa TYK2 Allosteric Inhibitor Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa TYK2 Allosteric Inhibitor Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa TYK2 Allosteric Inhibitor Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa TYK2 Allosteric Inhibitor Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of TYK2 Allosteric Inhibitor
Table 58. Key Market Challenges & Risks of TYK2 Allosteric Inhibitor
Table 59. Key Industry Trends of TYK2 Allosteric Inhibitor
Table 60. TYK2 Allosteric Inhibitor Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. TYK2 Allosteric Inhibitor Distributors List
Table 63. TYK2 Allosteric Inhibitor Customer List
Table 64. Global TYK2 Allosteric Inhibitor Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global TYK2 Allosteric Inhibitor Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas TYK2 Allosteric Inhibitor Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas TYK2 Allosteric Inhibitor Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC TYK2 Allosteric Inhibitor Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC TYK2 Allosteric Inhibitor Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe TYK2 Allosteric Inhibitor Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe TYK2 Allosteric Inhibitor Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa TYK2 Allosteric Inhibitor Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa TYK2 Allosteric Inhibitor Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global TYK2 Allosteric Inhibitor Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global TYK2 Allosteric Inhibitor Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global TYK2 Allosteric Inhibitor Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global TYK2 Allosteric Inhibitor Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Bristol-Myers Squibb Basic Information, TYK2 Allosteric Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 79. Bristol-Myers Squibb TYK2 Allosteric Inhibitor Product Portfolios and Specifications
Table 80. Bristol-Myers Squibb TYK2 Allosteric Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. Bristol-Myers Squibb Main Business
Table 82. Bristol-Myers Squibb Latest Developments
Table 83. InnoCare Pharma Basic Information, TYK2 Allosteric Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 84. InnoCare Pharma TYK2 Allosteric Inhibitor Product Portfolios and Specifications
Table 85. InnoCare Pharma TYK2 Allosteric Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. InnoCare Pharma Main Business
Table 87. InnoCare Pharma Latest Developments
Table 88. Takeda (Nimbus Therapeutics) Basic Information, TYK2 Allosteric Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 89. Takeda (Nimbus Therapeutics) TYK2 Allosteric Inhibitor Product Portfolios and Specifications
Table 90. Takeda (Nimbus Therapeutics) TYK2 Allosteric Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. Takeda (Nimbus Therapeutics) Main Business
Table 92. Takeda (Nimbus Therapeutics) Latest Developments
Table 93. Alumis Inc. Basic Information, TYK2 Allosteric Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 94. Alumis Inc. TYK2 Allosteric Inhibitor Product Portfolios and Specifications
Table 95. Alumis Inc. TYK2 Allosteric Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. Alumis Inc. Main Business
Table 97. Alumis Inc. Latest Developments
Table 98. Ventyx Biosciences Basic Information, TYK2 Allosteric Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 99. Ventyx Biosciences TYK2 Allosteric Inhibitor Product Portfolios and Specifications
Table 100. Ventyx Biosciences TYK2 Allosteric Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. Ventyx Biosciences Main Business
Table 102. Ventyx Biosciences Latest Developments
Table 103. BeiGene Basic Information, TYK2 Allosteric Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 104. BeiGene TYK2 Allosteric Inhibitor Product Portfolios and Specifications
Table 105. BeiGene TYK2 Allosteric Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. BeiGene Main Business
Table 107. BeiGene Latest Developments
LIST OF FIGURES
Figure 1. Picture of TYK2 Allosteric Inhibitor
Figure 2. TYK2 Allosteric Inhibitor Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global TYK2 Allosteric Inhibitor Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global TYK2 Allosteric Inhibitor Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. TYK2 Allosteric Inhibitor Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Oral Preparations
Figure 10. Product Picture of Topical Drugs
Figure 11. Global TYK2 Allosteric Inhibitor Sales Market Share by Type in 2023
Figure 12. Global TYK2 Allosteric Inhibitor Revenue Market Share by Type (2019-2024)
Figure 13. TYK2 Allosteric Inhibitor Consumed in Psoriasis
Figure 14. Global TYK2 Allosteric Inhibitor Market: Psoriasis (2019-2024) & (K Units)
Figure 15. TYK2 Allosteric Inhibitor Consumed in Atopic Dermatitis
Figure 16. Global TYK2 Allosteric Inhibitor Market: Atopic Dermatitis (2019-2024) & (K Units)
Figure 17. TYK2 Allosteric Inhibitor Consumed in Other
Figure 18. Global TYK2 Allosteric Inhibitor Market: Other (2019-2024) & (K Units)
Figure 19. Global TYK2 Allosteric Inhibitor Sales Market Share by Application (2023)
Figure 20. Global TYK2 Allosteric Inhibitor Revenue Market Share by Application in 2023
Figure 21. TYK2 Allosteric Inhibitor Sales Market by Company in 2023 (K Units)
Figure 22. Global TYK2 Allosteric Inhibitor Sales Market Share by Company in 2023
Figure 23. TYK2 Allosteric Inhibitor Revenue Market by Company in 2023 ($ Million)
Figure 24. Global TYK2 Allosteric Inhibitor Revenue Market Share by Company in 2023
Figure 25. Global TYK2 Allosteric Inhibitor Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global TYK2 Allosteric Inhibitor Revenue Market Share by Geographic Region in 2023
Figure 27. Americas TYK2 Allosteric Inhibitor Sales 2019-2024 (K Units)
Figure 28. Americas TYK2 Allosteric Inhibitor Revenue 2019-2024 ($ Millions)
Figure 29. APAC TYK2 Allosteric Inhibitor Sales 2019-2024 (K Units)
Figure 30. APAC TYK2 Allosteric Inhibitor Revenue 2019-2024 ($ Millions)
Figure 31. Europe TYK2 Allosteric Inhibitor Sales 2019-2024 (K Units)
Figure 32. Europe TYK2 Allosteric Inhibitor Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa TYK2 Allosteric Inhibitor Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa TYK2 Allosteric Inhibitor Revenue 2019-2024 ($ Millions)
Figure 35. Americas TYK2 Allosteric Inhibitor Sales Market Share by Country in 2023
Figure 36. Americas TYK2 Allosteric Inhibitor Revenue Market Share by Country in 2023
Figure 37. Americas TYK2 Allosteric Inhibitor Sales Market Share by Type (2019-2024)
Figure 38. Americas TYK2 Allosteric Inhibitor Sales Market Share by Application (2019-2024)
Figure 39. United States TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC TYK2 Allosteric Inhibitor Sales Market Share by Region in 2023
Figure 44. APAC TYK2 Allosteric Inhibitor Revenue Market Share by Regions in 2023
Figure 45. APAC TYK2 Allosteric Inhibitor Sales Market Share by Type (2019-2024)
Figure 46. APAC TYK2 Allosteric Inhibitor Sales Market Share by Application (2019-2024)
Figure 47. China TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 51. India TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe TYK2 Allosteric Inhibitor Sales Market Share by Country in 2023
Figure 55. Europe TYK2 Allosteric Inhibitor Revenue Market Share by Country in 2023
Figure 56. Europe TYK2 Allosteric Inhibitor Sales Market Share by Type (2019-2024)
Figure 57. Europe TYK2 Allosteric Inhibitor Sales Market Share by Application (2019-2024)
Figure 58. Germany TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 59. France TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa TYK2 Allosteric Inhibitor Sales Market Share by Country in 2023
Figure 64. Middle East & Africa TYK2 Allosteric Inhibitor Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa TYK2 Allosteric Inhibitor Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa TYK2 Allosteric Inhibitor Sales Market Share by Application (2019-2024)
Figure 67. Egypt TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of TYK2 Allosteric Inhibitor in 2023
Figure 73. Manufacturing Process Analysis of TYK2 Allosteric Inhibitor
Figure 74. Industry Chain Structure of TYK2 Allosteric Inhibitor
Figure 75. Channels of Distribution
Figure 76. Global TYK2 Allosteric Inhibitor Sales Market Forecast by Region (2025-2030)
Figure 77. Global TYK2 Allosteric Inhibitor Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global TYK2 Allosteric Inhibitor Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global TYK2 Allosteric Inhibitor Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global TYK2 Allosteric Inhibitor Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global TYK2 Allosteric Inhibitor Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of TYK2 Allosteric Inhibitor
Figure 2. TYK2 Allosteric Inhibitor Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global TYK2 Allosteric Inhibitor Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global TYK2 Allosteric Inhibitor Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. TYK2 Allosteric Inhibitor Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Oral Preparations
Figure 10. Product Picture of Topical Drugs
Figure 11. Global TYK2 Allosteric Inhibitor Sales Market Share by Type in 2023
Figure 12. Global TYK2 Allosteric Inhibitor Revenue Market Share by Type (2019-2024)
Figure 13. TYK2 Allosteric Inhibitor Consumed in Psoriasis
Figure 14. Global TYK2 Allosteric Inhibitor Market: Psoriasis (2019-2024) & (K Units)
Figure 15. TYK2 Allosteric Inhibitor Consumed in Atopic Dermatitis
Figure 16. Global TYK2 Allosteric Inhibitor Market: Atopic Dermatitis (2019-2024) & (K Units)
Figure 17. TYK2 Allosteric Inhibitor Consumed in Other
Figure 18. Global TYK2 Allosteric Inhibitor Market: Other (2019-2024) & (K Units)
Figure 19. Global TYK2 Allosteric Inhibitor Sales Market Share by Application (2023)
Figure 20. Global TYK2 Allosteric Inhibitor Revenue Market Share by Application in 2023
Figure 21. TYK2 Allosteric Inhibitor Sales Market by Company in 2023 (K Units)
Figure 22. Global TYK2 Allosteric Inhibitor Sales Market Share by Company in 2023
Figure 23. TYK2 Allosteric Inhibitor Revenue Market by Company in 2023 ($ Million)
Figure 24. Global TYK2 Allosteric Inhibitor Revenue Market Share by Company in 2023
Figure 25. Global TYK2 Allosteric Inhibitor Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global TYK2 Allosteric Inhibitor Revenue Market Share by Geographic Region in 2023
Figure 27. Americas TYK2 Allosteric Inhibitor Sales 2019-2024 (K Units)
Figure 28. Americas TYK2 Allosteric Inhibitor Revenue 2019-2024 ($ Millions)
Figure 29. APAC TYK2 Allosteric Inhibitor Sales 2019-2024 (K Units)
Figure 30. APAC TYK2 Allosteric Inhibitor Revenue 2019-2024 ($ Millions)
Figure 31. Europe TYK2 Allosteric Inhibitor Sales 2019-2024 (K Units)
Figure 32. Europe TYK2 Allosteric Inhibitor Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa TYK2 Allosteric Inhibitor Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa TYK2 Allosteric Inhibitor Revenue 2019-2024 ($ Millions)
Figure 35. Americas TYK2 Allosteric Inhibitor Sales Market Share by Country in 2023
Figure 36. Americas TYK2 Allosteric Inhibitor Revenue Market Share by Country in 2023
Figure 37. Americas TYK2 Allosteric Inhibitor Sales Market Share by Type (2019-2024)
Figure 38. Americas TYK2 Allosteric Inhibitor Sales Market Share by Application (2019-2024)
Figure 39. United States TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC TYK2 Allosteric Inhibitor Sales Market Share by Region in 2023
Figure 44. APAC TYK2 Allosteric Inhibitor Revenue Market Share by Regions in 2023
Figure 45. APAC TYK2 Allosteric Inhibitor Sales Market Share by Type (2019-2024)
Figure 46. APAC TYK2 Allosteric Inhibitor Sales Market Share by Application (2019-2024)
Figure 47. China TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 51. India TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe TYK2 Allosteric Inhibitor Sales Market Share by Country in 2023
Figure 55. Europe TYK2 Allosteric Inhibitor Revenue Market Share by Country in 2023
Figure 56. Europe TYK2 Allosteric Inhibitor Sales Market Share by Type (2019-2024)
Figure 57. Europe TYK2 Allosteric Inhibitor Sales Market Share by Application (2019-2024)
Figure 58. Germany TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 59. France TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa TYK2 Allosteric Inhibitor Sales Market Share by Country in 2023
Figure 64. Middle East & Africa TYK2 Allosteric Inhibitor Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa TYK2 Allosteric Inhibitor Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa TYK2 Allosteric Inhibitor Sales Market Share by Application (2019-2024)
Figure 67. Egypt TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country TYK2 Allosteric Inhibitor Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of TYK2 Allosteric Inhibitor in 2023
Figure 73. Manufacturing Process Analysis of TYK2 Allosteric Inhibitor
Figure 74. Industry Chain Structure of TYK2 Allosteric Inhibitor
Figure 75. Channels of Distribution
Figure 76. Global TYK2 Allosteric Inhibitor Sales Market Forecast by Region (2025-2030)
Figure 77. Global TYK2 Allosteric Inhibitor Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global TYK2 Allosteric Inhibitor Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global TYK2 Allosteric Inhibitor Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global TYK2 Allosteric Inhibitor Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global TYK2 Allosteric Inhibitor Revenue Market Share Forecast by Application (2025-2030)
